217 related articles for article (PubMed ID: 18456920)
1. Exenatide and rare adverse events.
Ahmad SR; Swann J
N Engl J Med; 2008 May; 358(18):1970-1; discussion 1971-2. PubMed ID: 18456920
[No Abstract] [Full Text] [Related]
2. Exenatide and rare adverse events.
Cure P; Pileggi A; Alejandro R
N Engl J Med; 2008 May; 358(18):1969-70; discussion 1971-2. PubMed ID: 18450614
[No Abstract] [Full Text] [Related]
3. Exenatide and acute pancreatitis.
Tripathy NR; Basha S; Jain R; Shetty S; Ramachandran A
J Assoc Physicians India; 2008 Dec; 56():987-8. PubMed ID: 19322980
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 analogues for type 2 diabetes.
Wilding JP; Hardy K
BMJ; 2011 Feb; 342():d410. PubMed ID: 21325387
[No Abstract] [Full Text] [Related]
5. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer.
Alves C; Batel-Marques F; Macedo AF
Diabetes Res Clin Pract; 2012 Nov; 98(2):271-84. PubMed ID: 23010561
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of acute pancreatitis in relation to exenatide use.
Dore DD; Bloomgren GL; Wenten M; Hoffman C; Clifford CR; Quinn SG; Braun DK; Noel RA; Seeger JD
Diabetes Obes Metab; 2011 Jun; 13(6):559-66. PubMed ID: 21320263
[TBL] [Abstract][Full Text] [Related]
7. Exenatide (Byetta) for type 2 diabetes.
Med Lett Drugs Ther; 2005 Jun; 47(1210):45-6. PubMed ID: 15933616
[TBL] [Abstract][Full Text] [Related]
8. Exenatide: excessive weight loss.
Prescrire Int; 2011 Jan; 20(112):17. PubMed ID: 21462789
[No Abstract] [Full Text] [Related]
9. An evidence-based and practical approach to using Bydureon™ in patients with type 2 diabetes.
Painter NA; Morello CM; Singh RF; McBane SE
J Am Board Fam Med; 2013; 26(2):203-10. PubMed ID: 23471935
[TBL] [Abstract][Full Text] [Related]
10. Exenatide. From the Gila monster to you. Exenatide is the first of a new class of drugs known as "incretin mimetics" that can enhance your blood glucose control.
Clark WL
Diabetes Self Manag; 2006; 23(1):36, 39-40. PubMed ID: 16453919
[No Abstract] [Full Text] [Related]
11. Exenatide: pancreatitis. Watch out for nausea and vomiting.
Prescrire Int; 2008 Jun; 17(95):112. PubMed ID: 18630353
[No Abstract] [Full Text] [Related]
12. Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.
Garber AJ
Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S279-84. PubMed ID: 21525469
[No Abstract] [Full Text] [Related]
13. [Beta-cell function in the foreground. GLP-1 based therapy of type 2 diabetes].
Kern W
MMW Fortschr Med; 2010 Jan; 151 Suppl 4():173-8. PubMed ID: 21595145
[No Abstract] [Full Text] [Related]
14. Q: Do incretin drugs for type 2 diabetes increase the risk of acute pancreatitis?
Olansky L
Cleve Clin J Med; 2010 Aug; 77(8):503-5. PubMed ID: 20682512
[No Abstract] [Full Text] [Related]
15. Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
Pinelli NR; Cha R; Brown MB; Jaber LA
Ann Pharmacother; 2008 Nov; 42(11):1541-51. PubMed ID: 18957626
[TBL] [Abstract][Full Text] [Related]
16. Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes.
Okerson T; Yan P; Stonehouse A; Brodows R
Am J Hypertens; 2010 Mar; 23(3):334-9. PubMed ID: 20019672
[TBL] [Abstract][Full Text] [Related]
17. [Novel therapy in type 2 diabetes: to regulate glucose metabolism naturally].
MMW Fortschr Med; 2005 Aug; 147(31-32):54-5. PubMed ID: 16128202
[No Abstract] [Full Text] [Related]
18. Exenatide and renal failure.
Ferrer-Garcia JC; Martinez-Chanza N; Tolosa-Torréns M; Sánchez-Juan C
Diabet Med; 2010 Jun; 27(6):728-9. PubMed ID: 20546299
[No Abstract] [Full Text] [Related]
19. [Blood sugar and pounds down, hardly hypoglycemias. New generation of antidiabetics ante portas].
Einecke D
MMW Fortschr Med; 2006 Aug; 148(35-36):4-6, 8, 10. PubMed ID: 16995353
[No Abstract] [Full Text] [Related]
20. Exenatide-induced depression in a geriatric patient.
Kohen I; Lester P
Int J Geriatr Psychiatry; 2008 Apr; 23(4):443-4. PubMed ID: 18383195
[No Abstract] [Full Text] [Related]
[Next] [New Search]
